Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

Lenta reported for 9 months of 2023

10/23/23 LENT

Lenta's operating performance is in the plus zone

10/23/23 LENT

CarMoney's loan portfolio reached ₽4.754 billion

10/23/23 CARM

In M.Video will open corners of Turkish and Chinese brands

10/23/23 MVID

Softline buys 5% of Moscow Exchange at a 60% discount

10/23/23 MOEX

Softline buys 5% of Moscow Exchange at a 60% discount

10/23/23 SOFL

Fesco expects container market growth of 15%

10/20/23 FESH

Fesco plans to purchase two narrow-body airplanes

10/20/23 FESH

INARCTICA reported for 9 months of 2023 by RAS

10/20/23 AQUA

Yakovlev reported for 9 months of 2023 by RAS

10/20/23 IRKT